Match Document Document Title
5654325 Melatonin derivatives for use in treating sleep disorders  
The present invention provides a method of treating sleep disorders using various melatonin analogs.
5654301 Amino acid derivative anticonvulsant  
The present invention relates to compounds of the formula ##STR1##
5652269 Substituted hydrazinecarboximidamides and methods of use thereof  
Modulators of neurotransmitter release including substituted guanidines, N"-aminoguanidines, and N,N'N",N"'-tetrasubstituted hydrazinedicarboximidamides, and pharmaceutical compositions thereof are...
5641801 Method of reducing the period before the onset of sleep  
Methods of inducing sleepiness and sleep in an individual by administering to that individual a single dose of melatonin sufficient to induce sleepiness and sleep in the individual.
5641800 1H-indole-1-functional sPLA.sub.2 inhibitors  
A class of novel 1H-indole-1-functional compounds is disclosed together with the use of such indole compounds for inhibiting sPLA 2 mediated release of fatty acids for treatment of conditions such...
5637593 Tryptamine analogues as 5-ht1-like agonists  
A compound of structure (I), in which A 1 is O, S(O) n in which n is 0, 1 or 2, NR, CH 2 , or CH(OH); A 2 is a bond or CH 2 ; or A 1 A 2 is CHCH; R is hydrogen or C 1 -4 alkyl; R 1 is an...
5635528 Intermediates to tetrahydro-beta-carbolines  
3-Ethanamine and 3-ethanamine related compounds are provided that are useful intermediates and have beneficial central nervous system activity.
5635537 8-substituted-2-aminotetralins  
A compound of the formula ##STR1## Z is hydrogen or halogen, Q is COR 1 or 5-or 6-membered aryl which may contain 1 or 2 heteroatoms selected from N, 0 or S and may be substituted or fused wherein...
5620998 N-acyl-N-heterocyclylalkylamino acid compounds and method of use thereof  
The invention relates to N-acyl-N-heterocyclylalkylamino acids of the formula ##STR1## wherein Y 1 is O, S or N(R) and R is hydrogen or C 1 -C 7 alkyl; X 1 is --CO-- or --S(O) m -- and the...
5618834 Indole derivatives in the treatment of emesis  
Compounds of formula I, ##STR1## wherein R 1 represents hydrogen; R 2 represents hydrogen, halogen, cyano, OR 4 , --(CH 2 ) m CONR 5 R 6 , --(CH 2 ) m SO 2 NR 5 R 6 , --(CH 2 ) m NR 7 COR...
5616605 Peptide derivatives of collagenase inhibitor  
This invention is directed to a collagenase inhibitor of the formula: ##STR1##
5612367 Method of enhancing bioavailability of pharmaceutical agents  
The invention provides a pharmaceutical composition comprising a particular physical form of N-[4-[5-(cyclopentyloxycarbonyl)amino-1-methylindol-3-yl-met hyl]-3-methoxy...
5610174 Use of α.sub.1A -selective adrenoceptor agonists for the treatment of urinary incontinence  
The present invention provides a method of treating urinary incontinence in a subject which comprises administering to the subject a therapeutically effective amount of a compound having the...
5610176 Tachykinin (NK1) receptor antagonists  
The invention concerns tachykinin antagonists. The compounds are alcohols, amines and prodrugs of nonpeptides which have utility in treating disorders mediated by tachykinins. Such disorders are...
5607961 Antidepressant 3-(aminocycloalkenyl)-indole-5-nitrile derivatives  
Certain 3-amino-cycloalkanyl and cycloalkenyl derivatives of 5-cyano-substituted indoles of Formula I are useful antidepressant agents. ##STR1## The substituent R 1 is hydrogen or C 1 -4 alkyl and...
5607960 Indole derivatives as 5-HT1-like agonists for use in migraine  
The present invention relates to 3,5-disubstituted indole compounds which are selective agonists which act on 5-hdroxytryptamine receptors useful in the treatment of migraine.
5607962 Substituted indole derivatives  
Substituted indole derivatives are prepared by reacting appropriate carboxylic acids, if appropriate in the presence of auxiliaries, with appropriate amines. The substituted indole derivatives are...
5604253 N-benzylindol-3-yl propanoic acid derivatives as cyclooxygenase inhibitors  
The invention encompasses the novel compound of Formula I as well as a method of treating cyclooxygenase-2 mediated diseases comprising administration to a patient in need of such treatment of a...
5599832 Indoles as insecticides and acaricides  
There are provided methods for the control of insects and the protection of crops from the damage caused thereby which comprise the use of compositions comprising an indole compound of formula I...
5594028 Anti-tumor method and compounds  
This invention provides certain sulfonamide derivatives, their pharmaceutical formulations, and their use in the treatment of susceptible neoplasms in mammals.
5594012 Amino acid derivatives and anti-active oxygen agents  
A novel anti-active oxygen agent which comprises as active ingredient an amino acid derivative represented by the following general formula (I): ##STR1## wherein Ar represents a 2-hydroxyphenyl,...
5583152 Method for treating vasospastic cardiovascular diseases heterocyclic amide derivatives  
The invention concerns novel, pharmaceutically useful, amide derivatives of certain benzoheterocyclylalkanoic acids (and related tetrazoles and acylsulphonamides) of the formula I and salts...
5583149 Antimigraine derivatives of indolylcycloalkanylamines  
A series of novel serotonergic indolyl derivatives of cycloalkanyl- and cycloalkenyl-amines of Formula I are intended for use in the alleviation of vascular headaches. ##STR1##
5576332 Soft β-drenegic blocking agents  
New soft β-adrenergic blocking agents, useful in the treatment or prevention of cardiovascular disorders and in the treatment of glaucoma, have the formula ##STR1## wherein n is an integer from 0...
5576321 Compounds having effects on serotonin-related systems  
A series of hetero-oxy alkanamines are effective pharmaceuticals for the treatment of conditions related to or affected by the reuptake of serotonin and by the serotonin 1 A receptor. The...
5571833 Tryptamine analogues, their synthesis and their use as 5-HT.sub.1 -like or 5-HT.sub.2 receptor agonists  
The present invention relates to known and novel tryptamine analogues, processes and intermediates useful in their preparation, pharmaceutical compositions containing them and their use in therapy,...
5571700 Process for preparing melanin pigments by bioconversion and use of the pigments obtained in cosmetics  
The present invention relates to a method for the preparation of a melanic pigment by enzymatic bioconversion, implementing a melanin precursor substrate and plant cells, characterized in that: (a)...
5559150 N,N-disulfonylated aminobenzene carboxlic acids and the use thereof as thrombin inhibitors  
The present invention is directed to novel compounds that are non-peptidic thrombin inhibitors. The compounds have the structure: ##STR1## and pharmaceutically acceptable salts thereof; wherein R 1...
5556864 α-ω-diarylalkane compounds serotonin-2 receptor agonists  
Compounds of formula (I): ##STR1## [wherein: R 1 is aryl; R 2 is hydrogen, alkyl, alkoxy, halogen or cyano; R 3 is a group of formula --B--NR 4 R 5 , where R 4 and R 5 are independently...
5554641 Nonpeptides as tachykinin antagonists  
The small nonpeptides of the instant invention are tachykinin antagonists. The compounds are highly selective and functional NK 3 antagonists expected to be useful in the treatment of pain,...
5554640 Use of propanolamine derivatives as selective 5-HT.sub.1 antagonists  
This invention provides a method of selectively antagonizing-the 5-HT 1A receptor in mammals by administering aryloxypropanolamines. Aryloxypropanolamines are also claimed.
5552428 Compounds effective in the treatment of circadian rhythms and related disorders, the novel pharmaceutical preparations and novel method of application  
The novel compounds of formula: ##STR1## in which R is isopropyl, cyclohexyl, phenyl, CH 3 , Br or I; or H R 1 is CH 3 or cyclopropyl and R 2 is H or Br, and when R 1 is cyclopropyl and R 2 is...
5550134 Methods for inhibiting bone loss  
The present invention provides methods of inhibiting bone loss in mammals via the administration to a mammal in need of such treatment an effective amount of a compound from a series of...
5543433 Azine-substituted phenylacetic acid derivatives and fungicides containing these  
Compounds of the formula I ##STR1## where X is hydrogen, halogen, alkyl, alkoxy, trifluoromethyl, cyano or nitro, Y is an amino, methylamino or dimethylamino group, Z is a group CHCH 3 ,...
5541204 Aryloxypropanolamine β 3 adrenergic agonists  
Compounds of the formula ##STR1## and pharmaceutically acceptable salts thereof wherein: R 1 to R 9 are as defined herein and m is the integer 0 or 1. These compounds are beta 3 adrenergic...
5538752 Melanin compositions and uses thereof and resulting products  
Compositions comprising melanin or melanin precursors are useful for preventing or controlling decay of substrates such as cellulosic and other porous organic substrates. The compositions provide...
5536749 Method for attenuation of sympathetic nervous system activity or onset of migraine by selectively metabolized beta-blocking agents  
Disclosed is a method for attenuating sympathetic nervous system hyperactivity or onset of migraine in a patient in need of such treatment, by the sublingual, buccal or intranasal administration to...
5532237 Indole derivatives with affinity for the cannabinoid receptor  
Disclosed are indole derivatives having activity on the cannabinoid receptors and the methods of their preparation. The compounds are useful for lowering ocular intra ocular pressure and treating...
5532243 Antipsychotic nitrogen-containing bicyclic compounds  
There are provided nitrogen-containing bicyclic compounds, pharmaceutical compositions containing these compounds and methods of using these compounds to treat physiological or drug-induced...
5521183 Use of 5-HT ligands as anti-pruritic agents  
The present invention is based on the finding that 5-HT receptor ligands are useful in treating experimental models of clinically encountered pruritus (itch). A 5-HT ligand as used in this...
5519033 Azabicyclo derivatives for treatment of urinary incontinence  
The present invention relates to a method of treating urinary incontinence in mammals, including humans, using certain quinuclidine derivatives, piperidine derivatives, azanorbornane derivatives of...
5514690 Aminocarbonyl (thiocarbonyl) and cyanoguanidine derivatives of quinoline and indoline  
Novel compounds having potassium channel activating activity and useful, for example, as antiischemic agents are disclosed. These compounds have the general formula ##STR1## wherein A is ##STR2##...
5510379 Sulfonate ACAT inhibitors  
β-Carboxy sulfonates of the formula ##STR1## wherein R 1 is aryl, R 3 and R 4 are hydrogen or alkyl, Y is -O-, -S-, or -NR 2 -, and R 5 is alkyl or aryl are potent inhibitors of the enzyme...
5510353 Certain aminoguanidine compounds, pharmaceutical compositions containing them and their use in treating gastrointestinal motility disorders and disorders associated with cephalic pain  
Compounds of formula A--X--Y--NH--B wherein A is derived from optionally substituted benzothiophene, indole, 4-aza-and 7-aza-benzothiophene or-indole, A bearing in position 5 hydrogen, halogen,...
5504101 5-HT-1D receptor ligands  
Described herein are tryptamine analogs that display high binding affinity and selectivity for the 5-HT1Dβ receptor, of the formula: ##STR1## wherein R 1 is a group selected from aryl-C 1 -7...
5502061 Peptidyl substituted benzamides and naphthamies  
The present invention provides HIV protease inhibitors, pharmaceutical formulations containing those compounds and methods of treating and/or preventing HIV infection and/or AIDS.
5498636 Treatment of angina pectoris  
This invention relates to a method for treating angina pectoris. Pursuant to this method, a β-adrenergic-blocking agent is administered acutely to a person having angina to provide an essentially...
5496844 Indole derivatives  
The present invention provides indole derivatives of the general formula: ##STR1## The indole derivatives of the invention have potent antiestrogen activity and are useful as drugs for the...
5494928 Indole derivatives  
The invention releates to indole derivatives of the formula ##STR1## wherein R 1 to R 4 are, independently, hydrogen, halogen, lower-alkyl, cycloalkyl or trifluoromethyl, R 5 and R 6 are,...
5494926 2/3-(heterocyclic alkyl amino)-1-(subst.-phenyl-methoxy)-ethanes/propanes as tachykinin-receptor antagonists  
Compounds of formula (I), and salts and prodrugs thereof, wherein Q represents phenyl or benzhydryl; X and Y each represent H or X and Y together form a group =0; Z is O, S or NR 8 (R 8 is H or C...